Vita 34 ROE 2024

Vita 34 ROE

-1.64

Vita 34 Dividend yield

3.11 %

Ticker

V3V.DE

ISIN

DE000A0BL849

WKN

A0BL84

In 2024, Vita 34's return on equity (ROE) was -1.64, a 1,828.45% increase from the -0.09 ROE in the previous year.

Vita 34 Aktienanalyse

What does Vita 34 do?

Vita 34 AG is a leading company in the field of stem cell technology. It was founded in Leipzig in 1997 and has since had an impressive history. The company focuses on the storage of stem cells from umbilical cord blood and umbilical cord tissue. These stem cells can be used later in life for the treatment of various diseases. The business model of Vita 34 AG involves customers storing and preserving their stem cells with them. The company offers various options to meet individual needs. Customers can choose between different packages that include different services. For example, a package can be booked that only includes the storage of umbilical cord blood, or another package that also includes the storage of umbilical cord tissue. In addition to stem cell storage, Vita 34 AG also offers various supplementary services. For example, customers can have genetic predisposition tests conducted to determine the risk for certain diseases. This allows customers to take targeted preventive measures and consider alternative treatment options if necessary. Another important aspect of Vita 34 AG's business is the trade of stem cells. By storing umbilical cord blood and tissue, the company builds an extensive portfolio of stem cells that can be sold to medical institutions when needed. The company works closely with doctors and research institutions to use the stem cells efficiently. Vita 34 AG operates not only in German-speaking countries but also has branches in other countries such as Austria, Switzerland, and the Netherlands. This allows the company to operate internationally and cater to the specific needs of individual countries. In addition to the mentioned services, Vita 34 AG also offers various products. For example, there are special storage kits for the storage of umbilical cord blood and tissue. Test kits for genetic predisposition tests can also be purchased. Vita 34 AG aims to increase awareness of stem cells and their therapeutic possibilities. Through intensive marketing, including in social networks, the company strives to ensure that as many people as possible learn about the benefits of stem cell technology and decide to store their stem cells with the company. Vita 34 AG has had an impressive development in recent years. It is now globally known and has established itself as a competent and reliable partner in the field of stem cell technology. With its wide range of services and products, it is often the first choice for many people when it comes to storing stem cells. Vita 34 ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Vita 34's Return on Equity (ROE)

Vita 34's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Vita 34's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Vita 34's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Vita 34’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Vita 34 Stock

What is the ROE (Return on Equity) of Vita 34 this year?

The ROE of Vita 34 this year is -1.64 undefined.

How has the Return on Equity (ROE) of Vita 34 developed compared to the previous year?

The ROE of Vita 34 has increased by 1,828.45% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Vita 34?

A high ROE indicates that Vita 34 generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Vita 34?

A low ROE can indicate that Vita 34 is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Vita 34 affect the company?

A change in ROE (Return on Equity) of Vita 34 can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Vita 34?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Vita 34?

Some factors that can influence Vita 34's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Vita 34 pay?

Over the past 12 months, Vita 34 paid a dividend of 0.16 EUR . This corresponds to a dividend yield of about 3.11 %. For the coming 12 months, Vita 34 is expected to pay a dividend of 0 EUR.

What is the dividend yield of Vita 34?

The current dividend yield of Vita 34 is 3.11 %.

When does Vita 34 pay dividends?

Vita 34 pays a quarterly dividend. This is distributed in the months of September, July, June, July.

How secure is the dividend of Vita 34?

Vita 34 paid dividends every year for the past 0 years.

What is the dividend of Vita 34?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Vita 34 located?

Vita 34 is assigned to the 'Health' sector.

Wann musste ich die Aktien von Vita 34 kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vita 34 from 6/7/2019 amounting to 0.16 EUR, you needed to have the stock in your portfolio before the ex-date on 6/5/2019.

When did Vita 34 pay the last dividend?

The last dividend was paid out on 6/7/2019.

What was the dividend of Vita 34 in the year 2023?

In the year 2023, Vita 34 distributed 0 EUR as dividends.

In which currency does Vita 34 pay out the dividend?

The dividends of Vita 34 are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Vita 34 stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Vita 34

Our stock analysis for Vita 34 Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vita 34 Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.